编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
---|---|---|---|---|
6111107 | A-836339 | 959746-77-1 | 98% | |
A-836339 is a cannabinoid CB2 receptor-selective agonist; exhibits high potencies at | ||||
6111105 | AB-MECA | 152918-26-8 | 98% | |
AB-MECA is a high affinity A3 adenosine receptor agonist, has high affinity for recom | ||||
6111104 | Amitifadine hydrochloride | 410074-74-7 | 98% | |
Amitifadine hydrochloride is a triple reuptake inhibitor (TRI) or serotonin-norepinep | ||||
6111101 | ATI-2341 | 1337878-62-2 | 98% | |
ATI-2341, pepducin targeting the C-X-C chemokine receptor type 4 (CXCR4), is an allos | ||||
6111022 | Auristatin F | 163768-50-1 | 98% | |
Auristatin F is a cytotoxic tubulin modifier with potent and selective antitumor acti | ||||
6111021 | Auristatin E | 160800-57-7 | 98% | |
Auristatin E is a cytotoxic tubulin modifier with potent and selective antitumor acti | ||||
6111011 | ABT-639 | 1235560-28-7 | 98% | |
ABT-639 is a novel, peripherally acting, selective T-type Ca2+ channel blocker. ABT-6 | ||||
6111001 | 3-aMino-1-Methyl-1H-pyrazole-4-carbonitrile | 21230-50-2 | 98% | |
3-aMino-1-Methyl-1H-pyrazole-4-carbonitrile 21230-50-2 | ||||
611935 | 360A | 794458-56-3 | 98% | |
360A is a strong affinity and selectivity inhibitor of G-quadruplex structures. | ||||
611916 | AT7519 trifluoroacetate | 1431697-85-6 | 98% | |
AT7519 trifluoroacetate is a multi-CDK inhibitor for CDK1, 2, 4, 6 and 9 with IC50 of | ||||
611810 | Ampkinone | 1233082-79-5 | 98% | |
Ampkinone is a small molecule activator of AMPK; stimulate functional activation of A | ||||
611806 | AT7867 dihydrochloride | 1431697-86-7 | 98% | |
AT7867 Hcl is a potent ATP-competitive inhibitor of Akt1/2/3 and p70S6K/PKA with IC50 | ||||
611805 | ARQ-092 | 1313881-70-7 | 98% | |
ARQ-092 is an Akt inhibitor extracted from patent US/20150299195A1, compound A. | ||||
611804 | Akt1 and Akt2-IN-1 | 893422-47-4 | 98% | |
Akt1 and Akt2-IN-1 is an allosteric inhibitor of Akt1 (IC50 = 3.5 nM) and Akt2 (IC50 | ||||
611803 | AKT inhibitor | 1004990-28-6 | 98% | |
AKT inhibitor is a broadly selective, potent, ATP-competitive Akt inhibitor, displays | ||||
611802 | A-674563 hydrochloride | 98% | ||
A-674563 hydrochloride is a potent selective Akt1 inhibitor with an IC50 of 14 nM; al | ||||
161014003 | Avasimibe | 166518-60-1 | 98% by HPLC | |
Avasimibe is a selective inhibitor of Cholesterol Acyltransferase 1 and CYP2C9. Avasi | ||||
161014002 | Apoptozole | 1054543-47-3 | 98% by HPLC | |
Apoptosis Activator VII, Apoptozole is a cell-permeable imidazole compound that direc | ||||
161009021 | AT7867 | 857531-00-1 (free base); 1431697-86-7 (2HCl) | 98% by HPLC | |
This ATP-competitive small molecule potently inhibits both AKT and p70S6K activity at | ||||
161009020 | AKT inhibitor VIII | 612847-09-3 | 98% by HPLC | |
AKT inhibitor VIII suppresses hyperthermia-induced Ndrg2 phosphorylation in gastric c | ||||
160926014 | AS-604850 | 648449-76-7 | 98% by HPLC | |
Treatment with this PI3K inhibitor enhanced myelination and axon number in the spinal | ||||
160926012 | AS-252424 | 900515-16-4 | 98% by HPLC | |
AS-252424 is a potent and selective small-molecule PI3Kgamma inhibitor. Oral administ | ||||
160926007 | AS-605240 | 648450-29-7 | 98% by HPLC | |
Orally administration of AS605240 significantly prevented lung inflammation and reduc | ||||
16071413 | Acalisib | 870281-34-8 | 98% by HPLC | |
Acalisib, also known as GS-9820, is an inhibitor of the beta and delta isoforms of th | ||||
16071301 | AZD8330 | 1204531-17-8 | 98% by HPLC | |
AZD8330 | ||||
16071109 | AZD-4547 | 1394854-62-6 | 98% by HPLC | |
AZD-4547 | ||||
16071104 | Apaziquone | 114560-48-4 | 98% by HPLC | |
Apaziquone, also known as EO9, EOquin, is a n indolequinone bioreductive prodrug and | ||||
16071021 | AF-353 | 865305-30-2 | 98% by HPLC | |
AF-353 is a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist, in | ||||
16071001 | AMG-517 | 659730-32-2 | 98% by HPLC | |
AMG 517 is a potent and selective TRPV1 antagonist, and antagonizes capsaicin, proton | ||||
16070919 | ascorbic acid | 89924-69-6 | 98% by HPLC | |
(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one |